ARTICLE | Company News
MorphoSys, Oridis antibody deal
September 17, 2001 7:00 AM UTC
MorphoSys (NMarkt:MOR) will characterize and validate antibodies to candidate targets with Oridis Biomed (Graz, Austria). MOR will apply its HuCAL technology to make antibodies to candidate targets, w...